-Completed Acquisitions of ZONTIVITY ® ; Toprol-XL ® and its Authorized Generic-
-Received U.S. Food and Drug Administration Approval and Launched YOSPRALA™-
-Provides Improved 2016 Full Year Guidance-
MISSISSAUGA, Ontario , Nov. 7, 2016 /CNW/ -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO) (“Aralez” or the “Company”) today announced financial results for the third quarter ended September 30, 2016 . The Company also highlighted certain corporate and commercial updates. All figures are in U.S. dollars.
